Skip to main content
| News

Kybora settles its European headquarters in Basel

18.03.2021

The American consultancy Kybora, which operates within the life sciences industry, has established its European headquarters in Basel. Kybora GmbH will offer its services to European pharmaceutical companies from its location in Basel.

Kybora, a consulting firm based in the USA, is continuing its growth course from Basel, where it has founded Kybora GmbH and established its European headquarters according to a press release. Kybora aims to use this location to provide European life sciences companies with services in the areas of mergers and acquisitions, licensing, capital procurement, and strategic consulting.

Alan Vanderborght, Founder and CEO of Kybora, is quoted in the press release, saying: “Basel is the ideal location for our European headquarter.” He adds that the city has a “renowned pharma environment and a vibrant biotech industry” and is an ideal location right next to France and Germany, giving them “access to some of the brightest talents in these sectors”. Basel Area Business & Innovation, the location promotion and innovation support agency, helped Kybora during the relocation process.

Jean Chatellier will lead Kybora’s new European headquarters as Managing Director. He can rely on two decades of professional experience and pre-existing customers that will now be looked after from the Basel site. He further plans to arrange new, long-term partnerships with companies in Basel and across Europe.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

KUORI developing biodegradable plastics
Advanced Manufacturing/AI, Basel Area Business & Innovation, Innovation, Invest, Sustainability

KUORI developing biodegradable plastics

The Basel-based cleantech company KUORI GmbH develops alternative materials for conventional plastics. The aim is to reduce the accumulation of...

Read More
Cell and gene therapies gain momentum in Basel
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Cell and gene therapies gain momentum in Basel

Companies specializing in the research and development of innovative cell and gene therapies continue to spring up all around the...

Read More
BLKB expanding support for startups
Basel Area Business & Innovation, Innovation, Invest

BLKB expanding support for startups

BLKB offers particularly promising SMEs and startups financial support within the framework of the “100 fürs Baselbiet” program. These companies...

Read More
Combatting the rise of antimicrobial resistance
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Combatting the rise of antimicrobial resistance

Antimicrobial resistance (AMR) is a growing global threat that, without intervention, could lead to as many as 10 million deaths...

Read More
AMR Action Fund invests in new antibiotics developed by BioVersys
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

AMR Action Fund invests in new antibiotics developed by BioVersys

The AMR Action Fund has made its first European investment in BioVersys, which is headquartered at Tech Park Basel. The...

Read More
Investors give Resistell 8.5 million Swiss francs
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Investors give Resistell 8.5 million Swiss francs

Resistell AG has secured 8.5 million Swiss francs in the first part of its series B funding round. The biotechnology...

Read More
1 2 3 31

Do you have a question? We'd like to hear from you.